Insider Weekends: Three Insiders of the Company Formerly Known as Valeant Pharmaceuticals Buy Stock

Welcome to edition 431 of Insider Weekends. Insider buying decreased significantly last week with insiders purchasing $40.96 million of stock compared to $106.41 million in the week prior. Selling also decreased with insiders selling $1.63 billion of stock last week compared to $1.72 billion in the week prior. With companies entering the traditional quiet period before the end of the third quarter, insider activity is likely to remain muted over the next few weeks.

Sell/Buy Ratio: The insider Sell/Buy ratio is calculated by dividing the total insider sales in a given week by total insider purchases that week. The adjusted ratio for last week went up to 39.79. In other words, insiders sold almost 40 times as much stock as they purchased. The Sell/Buy ratio this week compares unfavorably with the prior week, when the ratio stood at 16.12.

Note: As mentioned in the first post in this series, certain industries have their preferred metrics such as same store sales for retailers, funds from operations (FFO) for REITs and revenue per available room (RevPAR) for hotels that provide a better basis for comparison than simple valuation metrics. However metrics like Price/Earnings, Price/Sales and Enterprise Value/EBITDA included below should provide a good starting point for analyzing the majority of stocks.

Notable Insider Buys:

1. Bausch Health Companies Inc. (BHC): $24.92

Shares of this pharmaceutical company were acquired by 3 insiders:

Only plus or premium subscribers can access this post. Subscribe today.